← All Sponsors
SPONSOR

Tyra Biosciences, Inc

Total Trials
2
Recruiting
2
Phases
Phase 2, Phase 1
Conditions studied: AchondroplasiaLocally Advanced CholangiocarcinomaIntrahepatic CholangiocarcinomaSolid TumorMetastatic Cholangiocarcinoma
NCT06842355 Phase 2
Recruiting

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

Achondroplasia
United States, Australia, Canada View Trial →
NCT06160752 Phase 1
Recruiting

Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations

Locally Advanced Cholangiocarcinoma
United States View Trial →